Washington, DC –(ENEWSPF)—June 3, 2015. As the U.S. House of Representatives considers H.R. 2578, Commerce, Justice, Science Appropriations Act, Representative Earl Blumenauer (OR-03) will offer an amendment to ensure that no funds are available to the Drug Enforcement Agency (DEA) to enforce inspections of physicians who prescribe buprenorphine – a Schedule III drug that is very effective in treating addiction to opioids, such as Vicodin and OxyCotin, on an outpatient basis.
